Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Array Biopharma, Inc. (NQ: ARRY)
5.850 USD  +0.190 (+3.36%)
Official Closing Price  /  Updated: 4:30 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Array Biopharma, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
May 15, 2013
from PR Newswire
Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference
May 08, 2013
from PR Newswire
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
May 06, 2013
Array MEK162 Phase 3 Trial Announced in Ovarian Cancer Read More
from PR Newswire
Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
May 06, 2013
-Targets difficult-to-treat patient population with few remaining options - Read More
from PR Newswire
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013
April 29, 2013
from PR Newswire
Array BioPharma Inc. and GT Advanced Technologies Inc. Analysis Reports: (NASDAQ: ARRY), (NASDAQ: GTAT)
April 23, 2013
from SBWire Direct - Latest Press Releases
Pre-Market Trading Commentary on High Volume Stocks: (NASDAQ: CYTK), (NASDAQ: ARRY)
April 15, 2013
from SBWire Direct - Latest Press Releases
Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
April 04, 2013
from PR Newswire
Morning Research on Sanofi, Keryx Biopharma, VIVUS, and Array BioPharma
March 27, 2013
from PR Newswire
2 Bio Stocks Reports: (NASDAQ: GALE), (NASDAQ: ARRY)
March 26, 2013
from SBWire Direct - Latest Press Releases
Morning Movers - StereotaxisInc, Veeco Instruments Inc, ACADIA Pharmaceuticals Inc, Array BiopharmaInc
March 25, 2013
from SBWire Direct - Latest Press Releases
Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
March 21, 2013
Hematology / oncology industry expert to lead promising development pipeline Read More
from PR Newswire
Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech's Industry Success
March 14, 2013
Five Star Equities Provides Stock Research on Array Biopharma and PDL BioPharma Read More
from Marketwired News Releases
Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
March 05, 2013
from PR Newswire
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
March 01, 2013
RDInvesting Provides Stocks Research on Anika Therapeutics and Array Biopharma Read More
from Marketwired News Releases
Array BioPharma To Present At The Cowen Annual Health Care Conference
February 26, 2013
from PR Newswire
Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
February 08, 2013
from PR Newswire
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013
February 04, 2013
MEK162 Phase 3 Trial to Start April 2013 Read More
from PR Newswire
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013
January 29, 2013
from PR Newswire
Biotech Industry Expected to Experience More M&A Activity in 2013
January 28, 2013
Five Star Equities Provides Stock Research on Array Biopharma and Venaxis Read More
from Marketwired News Releases
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
December 27, 2012
from PR Newswire
Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
December 10, 2012
ARRY-520 and ARRY-614 demonstrate encouraging clinical activity for hematological cancers Identification of biomarker for ARRY-520 may enable better patient selection Read More
from PR Newswire
Array BioPharma Announces Exercise And Closing Of Underwriters' Over-Allotment Option
December 05, 2012
from PR Newswire
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012
November 28, 2012
Five Star Equities Provides Stock Research on Array Biopharma and Sunesis Pharmaceuticals Read More
from Marketwired News Releases
Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
November 15, 2012
from PR Newswire
Free Research Reports on ARRY, CECO, GILD and NKTR Issued by the Bedford Report
November 13, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Array BioPharma Announces Pricing Of Public Offering Of Common Stock
November 09, 2012
from PR Newswire
Array BioPharma Announces Proposed Public Offering Of Common Stock
November 08, 2012
from PR Newswire
MEK162 Registration Path Announced
November 08, 2012
-Pivotal trials in patients with NRAS mutant melanoma expected to begin in 2013- Read More
from PR Newswire
Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences
November 07, 2012
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here